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Antimicrobial therapy is a key factor in our success against
pathogens poised to ravage at risk or infected individuals.
However, we are currently at a watershed point as we face a
growing crisis of antibiotic resistance among diverse pathogens.
One area of intense interest is the impact of the application of
antibiotics for uses other than the treatment of patients and
the association with such utilization with emerging drug resis-
tance. This Research Topic “Low-dose antibiotics: current sta-
tus and outlook for the future” in Frontiers in Microbiology:
Antimicrobials, Resistance, and Chemotherapy details various
aspects of the wide ranging effects of antimicrobial therapy from
areas such as the regulation of host responses to modulation of
bacterial virulence factors to acquisition of antibiotic resistance
genes.
A remarkable and often overlooked fundamental of antibiotics
is that they have biological activities beyondmicrobial killing. The
host modulatory aspects of macrolides, tetracyclines, and beta-
lactams are reviewed by Aminov (2013a) underscoring how, for
example, macrolides such as azithromycin are routinely used for
immunomodulation in patients with chronic pulmonary disease
rather than for an antimicrobial effect. Azithromycin is also used
as a tool by Imperi et al. to detail how non-conventional thinking
about regulating virulence factors or modifying host inflamma-
tory cascades are useful to combating major pathogens such as
Pseudomonas aeruginosa (Imperi et al., 2014). Along this line,
Morita and colleagues carefully detail the pleotropic responses
of P. aeruginosa to sub-therapeutic levels of several antibacterials
and propose avenues to pursue to combat this pathogen, such as
developing efflux pump inhibitors (Morita et al., 2014). In their
article, Charlebois et al. show Clostridium perfringens biofilm
can be regulated by certain antibiotics at low concentrations
(Charlebois et al., 2014). For example, low dose bacitracin signif-
icantly enhances biofilm formation whereas low dose penicillin
reduces biofilm. This work underscores how there are untoward
effects that are not predictable when antimicrobials are admin-
istered at low concentrations. Providing a view on specific host
effector pathways with antimicrobials, Mihu et al. detail how
antifungal medications effectively stimulate host responses via
engagement with toll-like receptors (Mihu et al., 2014). In light
of the expanding difficulties with drug resistance and a lack of
therapeutics to combat them, Clark presents a cogent call for
pursing Ca2+ modulating strategies where by host Ca2+ home-
ostasis is modulated to block pathogens from effectively utilizing
this essential element (Clark, 2013).
An important focus in this Research Topic is the use
of antibiotics as growth enhancers in animals. Sorensen and
colleagues provide key insights into the effects of scientific
evidence on the policy decisions on the use of low-dose antimi-
crobials in livestock for growth promotion and disease preven-
tion particularly delineating how data have led to the European
Union’s ban of low-dose antimicrobials whereas their use in
the United States of America remains in flux (Sorensen et al.,
2014). The bottom line is that there is an urgent need to develop
policy based on well derived data, with this data being eas-
ily and widely available to independent parties. The articles by
Cheng et al. (2014), Chattopadhyay (2014), and Hao et al. (2014)
all further underscore critically important facets of the contin-
ued utilization of antibiotics in animal husbandry. Looft and
colleagues detail their research on how the use of the in-feed
antibiotic carbadox cases dramatic short- and long-term effects
on the composition of porcine gut microbiota (Looft et al., 2014).
Diarra and Malouin specifically describe the impact of antibi-
otics in Canadian poultry production and describe the use of
alternatives, such as bioactive molecules from cranberries, that
should not drive antibiotic resistance (Diarra andMalouin, 2014).
Similarly, Rendondo et al. provide thoughtful insights into the use
of tannins in lieu of antibiotics for improving health in poultry
(Redondo et al., 2014). Lin details that the effective of antibi-
otics as growth promoters is linked to decreased activities of bile
salt hydrolase, which thus makes targeting this enzyme directly
a promising method for removing antibiotics for use as growth
enhancers (Lin, 2014).
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You and Silbergeld critically discuss the effects of
antimicrobials as drivers of resistome expansion (You and
Silbergeld, 2014), a major secondary effect due to environmental
pollution. The effects of antibiotics permeating our environment
are highlighted by Conro and colleagues who present their
findings that the presence of antibiotics in aquatic environments
can induce co-aggregation of bacterial species as an effective
mechanism to combat the effects of the antimicrobials (Corno
et al., 2014), which can lead to extensive resistance through the
transfer of resistance genes among these aggregated bacteria. It is
a small leap for these microbes to then impact humans and other
organisms. Aminov provides the example of the rampant use of
tetracyclines for non-medical purposes as driving the penetration
of tet(X) into pathogenic microbial communities (Aminov,
2013b). Chowdhury and colleagues eloquently discuss the import
of surveillance strategies for critically elucidating the emergence
of drug resistant pathogens in the context of low-dose antibiotic
use in animal husbandry (Roy Chowdhury et al., 2014).
In summary, the articles within this Research Topic serve as
a “call to arms” for scientists, policy makers and the public to
be increasingly vigilant about the use of antimicrobials, partic-
ularly in low-dose or where they can become widespread in the
environment, in order to maintain our capacity to effectively care
for individuals with infectious diseases. The articles also provide
new concepts for approaches for the development of antimicro-
bials as well as for novel growth enhancers for the use in animal
husbandry.
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